CCND1 and MET Genomic Amplification During Malignant Transformation of a Giant Cell Tumor of Bone-Reference-Cited by-同舟云学术

CCND1 and MET Genomic Amplification During Malignant Transformation of a Giant Cell Tumor of Bone

Published:2011-02-01 Issue:4 Volume:29 Page:e86-e89
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Saâda Esma¹,Peoc'h Michel²,Decouvelaere Anne-Valérie³,Collard Olivier⁴,Peyron Annie-Claude⁵,Pedeutour Florence¹

Affiliation:

1. Laboratory of Solid Tumors Genetics, Nice University Hospital, and Faculty of Medicine, University of Nice Sophia-Antipolis, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 6543, Nice, France

2. Saint-Etienne University Hospital, Saint-Etienne, France

3. Centre Léon Bérard, Lyon, France

4. Institut de Cancérologie de la Loire, Saint-Priest en Jarez, France

5. Laboratory of Solid Tumors Genetics, Nice University Hospital, Nice, France

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.31.4286

Reference23 articles.

1. University of California, Santa Cruz (UCSC) Genome Bioinformatics, Genome Browser, March 2006 and May 2004 releases http://www.genome.ucsc.edu

2. Massive Resection and Allograft Transplantation in the Treatment of Malignant Bone Tumors

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histological and immunohistochemical features and genetic alterations in the malignant progression of giant cell tumor of bone: a possible association with TP53 mutation and loss of H3K27 trimethylation;Modern Pathology;2021-11-16

2. Giant cell tumor of bone: updated molecular pathogenesis and tumor biology;Human Pathology;2018-11

3. Met Activation and Carcinogenesis;Current Human Cell Research and Applications;2017-11-17

4. Giant Cell Tumor of Bone;Diagnostic Pathology: Molecular Oncology;2016

5. Prognostic value of MET protein overexpression and gene amplification in locoregionally advanced nasopharyngeal carcinoma;Oncotarget;2015-04-20